SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 325 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $109,137,904 | -34.7% | 953,003 | -21.5% | 0.13% | -38.3% |
| Q1 2023 | $167,236,857 | +138579.9% | 1,213,356 | +30.4% | 0.21% | +20.1% |
| Q4 2022 | $120,592 | -99.8% | 930,643 | +39.5% | 0.17% | +59.6% |
| Q3 2022 | $73,735,000 | +725.3% | 667,044 | +459.7% | 0.11% | +808.3% |
| Q2 2022 | $8,934,000 | +30.2% | 119,187 | +35.7% | 0.01% | +50.0% |
| Q1 2022 | $6,863,000 | -17.3% | 87,856 | -4.7% | 0.01% | 0.0% |
| Q4 2021 | $8,297,000 | +10.9% | 92,142 | +13.9% | 0.01% | 0.0% |
| Q3 2021 | $7,479,000 | – | 80,872 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |